Accuracy, efficacy and safety of dengue CYD-TDV pre-vaccination screening with 5 existing IgG serotests: Retrospective analysis of phase III trials

• C. Diazgranados,
• M. Bonaparte,
• Y. Lustig,
• R. Forrat,
• G. Dayan,
• H. Wang,
• M. Zhu,
• S. Hodge,
• E. Schwartz,
• Y. Ataman-Onal,
• S. Savarino

Affiliations

C. Diazgranados

Sanofi Pasteur, Global Clinical Sciences, Marcy l’Etoile, France

M. Bonaparte

Sanofi Pasteur, Global Clinical Immunology, Swiftwater, United States

Y. Lustig

Chaim Sheba Medical Center, Central Virology Laboratory, Ramat Gan, Israel

R. Forrat

Sanofi Pasteur, Global Clinical Sciences, Marcy l’Etoile, France

G. Dayan

Sanofi Pasteur, Global Clinical Sciences, Swiftwater, United States

H. Wang

Sanofi, Biostatistics, Beijing, People's Republic of China

M. Zhu

Sanofi Pasteur, Biostatistics, Swiftwater, United States

S. Hodge

Sanofi Pasteur, Global Clinical Immunology, Swiftwater, United States

E. Schwartz

Chaim Sheba Medical Center, Institute of Tropical Medicine, Ramat Gan, Israel

Y. Ataman-Onal

Sanofi Pasteur, Translational Sciences and Biomarkers, Marcy l’Etoile, France

S. Savarino

Sanofi Pasteur, Translational Sciences and Biomarkers, Swiftwater, PA, United States; Corresponding author.